Recovery and quality of life after corneal transplant
Part of Eyes & vision clinical trials.
This study looks at how well people recover after a corneal transplant, including their vision, eye health, and overall quality of life. It aims to learn what helps people heal best after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a corneal disease that requires a corneal transplant (surgery to replace the damaged part of your eye).
- You must sign a consent form to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with diseases of the eye surface (the clear front part of the eye) to find out which factors predict how well their vision will be after treatment. By joining, you help researchers learn more about these conditions and what may affect visual recovery.
This study looks at how well people do after a specific type of corneal transplant called posterior lamellar keratoplasty. It aims to understand long-term outcomes for patients who had this surgery.
This trial studies whether pretreatment with a specific vitamin and ultraviolet light can help a future, high-risk corneal transplant keep its new cornea healthy for longer. It may help people whose corneas already have new blood vessels, which can make transplant results harder.
This study tests an artificial cornea (a small plastic implant) to see if it can safely improve vision in people who are blind from corneal damage and cannot have a regular cornea transplant. It aims to help those with no other good treatment options.
This study tests a new approach to help prevent cornea transplant failure in people with high-risk conditions, such as blood vessels growing into the cornea. It aims to see if this treatment can improve transplant success.
This study tests how well a patient’s corneal lining cells are preserved before corneal transplantation, and uses that to guide the transplant approach. It may help improve transplant planning and outcomes for people who need treatment for conditions like keratoconus or Fuchs endothelial dystrophy.
Hear when a new Cornea Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.